Modulation of human neutrophil chemotactic responses by cyclic 3',5'-guanosine monophosphate and cyclic 3',5'-adenosine monophosphate.
about
Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187Inhibition of the inflammatory action of interleukin-1 and tumor necrosis factor (alpha) on neutrophil function by pentoxifylline.Effect of cyclic adenosine 3',5'-monophosphate antagonists on endotoxin-induced inhibition of human neutrophil chemotaxisInhibition of human neutrophil chemotaxis in vitro by phenothiazines and related compounds.Inhibition of human neutrophil chemotaxis and chemiluminescence by amphotericin B.Effect of chemoattractants on chemiluminescence.The effects of anesthesia and surgery on count and function of neutrophils.Inhibitory role of sphingosine 1-phosphate receptor 2 in macrophage recruitment during inflammation.Phorbol myristate acetate modulates calcium ion-dependent superoxide anion generation induced by a monoclonal antibody raised against polymorphonuclear leukocytes.Studies on changes of beta-adrenergic receptors in polymorphonuclear cell and mononuclear cell with the changes of thyroid functionNeutrophil aggregation and degranulation. Effect of arachidonic acid.Hormetic dose-response relationships in immunology: occurrence, quantitative features of the dose response, mechanistic foundations, and clinical implications.Chemotaxis by polymorphonuclear leukocytes.The inhibition of neutrophil granule enzyme secretion and chemotaxis by pertussis toxin.Adenosine promotes neutrophil chemotaxis.Protein degradation in normal and beige (Chediak-Higashi) mice,.Cholera toxin inhibits chemotaxis by a cAMP-independent mechanism.Prostaglandins and their regulation in rheumatoid inflammation.Tuftsin: its chemistry, biology, and clinical potential.Prostaglandins and the modulation of immunological responses.IgE-mediated basophil phenomena: quantitation, control, inflammatory interactions.Comments on possible long-term consequences of nonsteroidal anti-inflammatory use.Chemotaxis in cutaneous disease.Erythromycin shortens neutrophil survival by accelerating apoptosis.High-dose catecholamine treatment decreases polymorphonuclear leukocyte phagocytic capacity and reactive oxygen production.Leucocyte response in the gingival crevice of the diabetic rat.Immunological alterations in psoriasis.Modulation of gingival cAMP levels by tissue inflammation.Effects of local anesthesia on gingival cAMP levels.Cutaneous manifestations of lithium toxicity.Lymphocyte suppressor activity in atopic eczema.Modulation of neutrophil function by lysozyme. Potential negative feedback system of inflammation.Potentiation and inhibition of migration of human neutrophils by auranofin.Adenosine inhibits polymorphonuclear leukocyte in vitro activation: a possible role as an endogenous calcium entry blocker.Prostaglandin E₂ inhibits human lung fibroblast chemotaxis through disparate actions on different E-prostanoid receptors.A possible role of arachidonic acid in human neutrophil aggregation and degranulation.Immunity in diabetes mellitus: impaired or enhanced?Human Leukocyte Cyclic AMP and Cyclic GMP Levels during Chemotaxis in Delayed Type Hypersensitivity
P2860
Q24597124-614635EE-31DC-4592-8FC0-D01AC2C3AC41Q30451069-60D3C115-7CDC-44A4-A303-37472A739BA8Q34083535-AAD390A2-DD2C-4220-A653-E163C709535EQ34134142-11856C3D-A55C-44B0-93DB-9EE30A1E8244Q34400726-6EEE64DE-E10B-4E8C-861D-817032EE1BDDQ34464368-7F9431B1-9C48-4D3F-825D-C3CE9B1F223CQ34549100-9C7D737A-18E9-4F34-BB72-548579237940Q34748080-45D84348-A904-4606-8EF9-D7149F65DED6Q35100751-E01CB638-5AEE-4FAA-80E4-4DEBCAB6FED6Q35948219-EEC0F6B8-1165-4B1D-A71C-BF408FB23D1BQ36092978-188F9A4F-8880-4545-8A5B-7D61577031D9Q36102139-7E8BA4DF-5572-490C-841C-50992A0882F8Q36199157-3D1EC4BA-BA5D-4169-8FB0-4C0BDDAD23CDQ36213406-AD3E1BE9-AA44-4B0F-94D3-C88C9AEFE09EQ36354651-F930CBD8-6D33-4098-B708-A649EBBC35A1Q37050390-AF908C36-273E-4CAE-B1BF-C9F3E31D1E7AQ37536449-F911537D-C78E-49E6-AE70-149BFE82083CQ38058870-7A1AE4D1-6F63-484F-AD85-6293A9D45893Q38672347-F080CD56-8D78-4470-B825-6A5C30CC3D0BQ39461788-803137F2-A556-40B3-88EC-F9B1CED284C2Q39513150-8CA04C63-BE17-495C-840E-EF4555F600E4Q39521982-CAD81D75-E890-4666-8D20-792C1FA9E310Q39723522-8E48F26E-E62E-4A89-9276-D1960D88A7D6Q39779501-126B2B6F-C1A6-4192-A06B-8ECD5B4CFDC4Q39810586-61951146-46D4-464C-90EF-1961F5B5FDF3Q39910344-F231C697-6744-4269-B3F6-ED217D132E7AQ40120662-995E0A6D-B303-4357-86B5-501BC14D1841Q40204903-C3709077-212D-4FD8-8C20-60ABF254C1A7Q40204910-4B8AC451-D86D-4164-A055-D0940AEBCFB9Q40219718-65E9AF7D-3C4C-4B52-BEB6-2BF0A97235DCQ40223092-95DD8E74-CD6D-406C-9BA0-E0024E013802Q40231973-F7C43145-599E-4E4C-9888-607E44CCDEC8Q41264899-D8628603-6589-46CA-AD1B-9CE5CCBF3186Q41490099-7324B62D-1888-4EE3-B7B4-471490134B47Q41764778-131ED678-1A81-460A-B88B-DC02ECAF810FQ41811890-DEAC858C-2112-426A-84D4-58CDB20DAB18Q41848413-53AC6C52-0F8E-43C0-B8C1-46863C7B2974Q57638534-A9D1F40A-93D3-4619-AAE2-1553E924000D
P2860
Modulation of human neutrophil chemotactic responses by cyclic 3',5'-guanosine monophosphate and cyclic 3',5'-adenosine monophosphate.
description
1975 nî lūn-bûn
@nan
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
1975年论文
@zh
1975年论文
@zh-cn
name
Modulation of human neutrophil ...... 3',5'-adenosine monophosphate.
@en
Modulation of human neutrophil ...... 3',5'-adenosine monophosphate.
@nl
type
label
Modulation of human neutrophil ...... 3',5'-adenosine monophosphate.
@en
Modulation of human neutrophil ...... 3',5'-adenosine monophosphate.
@nl
prefLabel
Modulation of human neutrophil ...... 3',5'-adenosine monophosphate.
@en
Modulation of human neutrophil ...... 3',5'-adenosine monophosphate.
@nl
P2093
P1433
P1476
Modulation of human neutrophil ...... 3',5'-adenosine monophosphate.
@en
P2093
P304
P356
10.1016/0026-0495(75)90124-9
P577
1975-03-01T00:00:00Z